Cencora ($COR) Insider Trading & Smart Money Activity
Cencora, Inc. ($COR) has 4 insider trades, 2 congress trades, 15 13F position changes and 3 analyst ratings on file. In the last 12 months on the open market, 2 insiders bought ($1.25M) and 1 insider sold ($298.94K), net +$946.45K.
- Insider buyers (12 mo)
- 2
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- +$946.45K
- Congress trades (12 mo)
- 2
- 13F moves on file
- 15
- Analyst ratings on file
- 3
COR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q2 2026 | 2 · $1.25M | 0 | 0 / 1 | 9 / 5 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $298.94K | 0 / 0 | 1 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All COR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | UBS | Reiterates to Buy | PT $400 | Read | |||||||
| 13F | Fort Washington Investment Advisors | Added | +185.06K sh | $129.64M | Read | ||||||
| Analyst | Leerink Partners | Reiterates to Outperform | PT $388 | +6.0% | — | ||||||
| Insider | Krikorian LazarusSVP & Chief Accounting Officer | Sell (Open-market sale) 10b5-1 | 986 sh | $298.94K | +3.7% | — | |||||
| Insider | Eva BorattoChief Financial Officer | Buy (Grant or award) | 21.30K sh | +6.0% | +13.1% | Read | |||||
| Insider | Lauren Tyler | Buy (Open-market buy) | 550 sh | $148.63K | +3.8% | +10.8% | — | ||||
| Insider | Durcan Dermot Mark | Buy (Open-market buy) | 4K sh | $1.10M | +5.6% | +11.8% | Read | ||||
| Analyst | Barclays | Reiterates to buy | PT $350 | -1.5% | +7.9% | — | |||||
| 13F | T. Rowe Price Investment Management | Reduced | -405.80K sh | $1.78B | +6.7% | +9.2% | — | ||||
| 13F | Holocene Advisors | Reduced | -56.17K sh | $238.02M | +6.7% | +9.2% | — | ||||
| 13F | First Manhattan | Reduced | -23.87K sh | $68.71M | +6.7% | +9.2% | — | ||||
| 13F | Exoduspoint Capital Management | Added | +8.71K sh | $16.28M | +1.9% | +8.0% | — | ||||
| 13F | Arrowstreet Capital, Limited Partnership | Reduced | -205.97K sh | $295.62M | +1.9% | +8.0% | — | ||||
| 13F | Arrowstreet Capital, Limited Partnership | Reduced | -205.97K sh | $293.48M | +1.9% | +8.0% | — | ||||
| 13F | Nordea Investment Management | Added | +53.70K sh | $370.72M | +3.8% | +10.4% | — | ||||
| 13F | Mitsubishi Ufj Asset Management | Added | +959.12K sh | $384.78M | +2.2% | +8.1% | — | ||||
| 13F | Great Lakes Advisors | Added | +8.07K sh | $98.32M | +2.2% | +8.1% | — | ||||
| 13F | Danske Bank A | New | +253.97K sh | $71.87M | +2.2% | +8.1% | — | ||||
| 13F | Federated Hermes | Added | +71.85K sh | $212.11M | +1.1% | +8.5% | — | ||||
| 13F | Boston Partners | Added | +286.28K sh | $1.27B | +1.1% | +8.5% | — | ||||
| Congress | Jared Moskowitz | Sale | $1,001 - $15,000 | +1.2% | +9.1% | Read | |||||
| 13F | Mawer Investment Management | Added | +412.88K sh | $291.80M | +1.2% | +9.1% | — | ||||
| 13F | Allspring Global Investments Holdings | Added | +29.98K sh | $116.89M | -14.7% | -11.4% | — | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +2.7% | -0.7% | -1.4% | — |
1W / 1M / 6M = how COR moved from the trade or filing date.
Insider trading in COR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Krikorian Lazarus | SVP & Chief Accounting Officer | 1 | -$298.94K | Oct 1, 2026 | |
| Eva Boratto | Chief Financial Officer | 1 | — | Jun 29, 2026 | |
| Lauren Tyler | 1 | +$148.63K | Jun 22, 2026 | ||
| Durcan Dermot Mark | 1 | +$1.10M | Jun 18, 2026 |
Members of Congress trading COR
Institutions moving COR (13F)
- Arrowstreet Capital, Limited Partnership2
- Fort Washington Investment Advisors1
- T. Rowe Price Investment Management1
- Holocene Advisors1
- First Manhattan1
- Exoduspoint Capital Management1
- Nordea Investment Management1
- Mitsubishi Ufj Asset Management1
- Great Lakes Advisors1
- Danske Bank A1
- Federated Hermes1
- Boston Partners1
Analyst ratings on COR
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| UBS | Reiterates | Buy | $430 → $400 | Read | ||||
| Leerink Partners | Reiterates | Outperform | $380 → $388 | +6.0% | — | |||
| Barclays | Reiterates | buy | $350 | -1.5% | +7.9% | — |
Frequently asked questions
Are COR insiders buying or selling?
Over the last 12 months 2 insiders made 2 open-market purchases worth $1.25M and 1 insider made 1 open-market sale worth $298.94K, a net +$946.45K.
What is the latest insider trade in COR?
Krikorian Lazarus, SVP & Chief Accounting Officer filed a sell (open-market sale) of 986 sh worth $298.94K on Oct 1, 2026.
Which members of Congress traded COR?
2 disclosed trades by Jared Moskowitz and Alan Armstrong. The latest was on May 6, 2026.
Which institutions changed their COR positions?
Recent 13F filers moving the stock include Arrowstreet Capital, Limited Partnership, Fort Washington Investment Advisors, T. Rowe Price Investment Management, Holocene Advisors and First Manhattan.
Other medical distribution stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.